Cleared Traditional

K053369 - MEDILOG DARWIN HOLTER ANALYSIS

K053369 is an FDA 510(k) clearance for MEDILOG DARWIN HOLTER ANALYSIS, manufactured by Huntleigh Healthcare. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 17-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2005
Decision
17d
Days
Class 2
Risk

K053369 is an FDA 510(k) clearance for the MEDILOG DARWIN HOLTER ANALYSIS. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Huntleigh Healthcare (Surrey, GB). The FDA issued a Cleared decision on December 22, 2005 after a review of 17 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Huntleigh Healthcare devices

FDA 510(k) Submission Details - K053369

510(k) Number K053369 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 2005
Decision Date December 22, 2005
Days to Decision 17 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
108d faster than avg
Panel avg: 125d · This submission: 17d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 271
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K053369.
MAC-LAB/CARDIOLAB /COMBOLAB/SPECIALSLAB SYSTEM
K061741 · Ge Healthcare · Sep 2006
NOGA XP CARDIAC NAVIGATION SYSTEM WITH QWIKMAP SOFTWARE
K053194 · Biosense Webster, Inc. · Mar 2006
DATEX-OHMEDA S/5 CARDIAC OUTPUT MODULE, E-COP AND ACCESSORIES
K052976 · Ge Healthcare · Jan 2006
DATEX-OHMEDA S/5 CARDIAC OUTPUT AND SVO2 MODULE, E-COPSV AND ACCESSORIES
K052977 · Ge Healthcare · Nov 2005
CARTO RMT EP NAVIGATION SYSTEM
K042681 · Biosense Webster, Inc. · Sep 2005
MARS HOLTER ANALYSIS WORKSTATION
K051026 · Ge Medical Systems Information Technologies · Jul 2005